Matevara Wellness has announced a major expansion to its Brain Health portfolio with a new formulation designed to support mental clarity, memory, and cognitiveMatevara Wellness has announced a major expansion to its Brain Health portfolio with a new formulation designed to support mental clarity, memory, and cognitive

From Brain Fog to Balance: Matevara Wellness Unveils New ‘Focus & Memory’ Formula for Cognitive Health

Matevara Wellness has announced a major expansion to its Brain Health portfolio with a new formulation designed to support mental clarity, memory, and cognitive balance for modern women. Addressing the “wired-but-tired” phenomenon, the brand is bridging the gap between ancient Ayurvedic healing and modern scientific validation.

We sat down with Brinda, Founder of Matevara Wellness, to discuss their “No Side Effects” philosophy, the benefits of Ashwagandha and Shilajit, and how their new ecosystem supports everything from metabolic balance to deep restorative sleep.

Q: You have just announced the launch of a new product for Focus & Memory, specifically targeting the “wired-but-tired” modern lifestyle. What was the driving force behind expanding your Targeted Health Support ecosystem to address this specific issue for women?

Brinda: “Matevara Wellness has announced the launch of its new product for Focus & Memory, a new addition to its expanding Brain Health portfolio designed to support mental clarity, memory, and cognitive balance for modern women. As part of Matevara’s broader Targeted Health Support ecosystem, which includes solutions for Brain Health, Sleep & Relaxation, and Women’s Health, the brand also offers complementary formulations such as Slumbra. Together, these targeted solutions reflect Matevara’s holistic approach to supporting focus by day and restorative recovery at night, without creating a sedated effect.”

Q: Your approach is described as holistic, pairing daytime focus with nighttime recovery. Can you explain how your Slumbra formulation complements this new product, specifically regarding the use of valerian and GABA for racing thoughts at night?

Brinda: “Matevara’s Slumbra Formula specifically targets the ‘wired-but-tired’ phenomenon by providing a valerian and GABA for racing thoughts at night, helping quiet the central nervous system, while its valerian root extract for deep sleep works to extend the duration of REM cycles. By pairing a valerian and GABA for racing thoughts at night for deep sleep, Matevara silences mental chatter to ensure high-quality REM recovery.”

Q: The new therapeutic line leverages powerful adaptogens like Ashwagandha and Shilajit. Beyond mental clarity, can you elaborate on the shilajit resin benefits for skin aging and how these ingredients contribute to overall endocrine balance?

Brinda: “Central to the formulation are the ashwagandha benefits for hormonal acne and PCOS support. By modulating the HPA axis to lower systemic cortisol, Ashwagandha helps stabilize the androgen fluctuations that often lead to adult acne and cycle irregularities. Complementing this, Matevara focuses on the shilajit resin benefits for skin aging and structural integrity. Recent clinical insights also highlight the best shilajit for women’s bone density, particularly as a preventative measure against age-related bone loss.”

Q: In an industry often crowded with products relying on synthetic fillers, Matevara stands by a strict “No Side Effects” philosophy. How do you ensure this level of purity and efficacy while maintaining the trust of your community?

Brinda: “At the core of Matevara’s mission is a commitment to purity and efficacy. Unlike many mass-market products that rely on synthetic fillers, Matevara’s formulations are inspired by centuries of healing tradition and validated through rigorous third-party lab testing. This dual approach ensures that every product delivers potent results without compromising safety. Our goal is to create products that our customers can rely on for a lifetime.”

Q: To celebrate this expanding product line, you are currently offering exclusive perks to your customers. What can new and existing users expect in terms of promotions and guarantees when they visit your site?

Brinda: “To celebrate its expanding product line, Matevara is currently offering exclusive perks, including free shipping on all orders and a ‘30% Off Sitewide’ promotion. Customers can also join the rewards program to unlock VIP offers. We want our community to experience the benefits of Ayurveda without any apprehensions, which is why we offer a 90-day full refund promise.”

For more information or to browse the full catalog, visit https://matevara.com/collections/all-product.

Comments
Market Opportunity
FOGNET Token Logo
FOGNET Token Price(FOG)
$0.01498
$0.01498$0.01498
+0.67%
USD
FOGNET Token (FOG) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Polymarket signals 98% chance Fed will keep rates steady in January meeting

Polymarket signals 98% chance Fed will keep rates steady in January meeting

The post Polymarket signals 98% chance Fed will keep rates steady in January meeting appeared on BitcoinEthereumNews.com. The US Federal Reserve is set to hold
Share
BitcoinEthereumNews2026/01/22 13:26
BlackRock boosts AI and US equity exposure in $185 billion models

BlackRock boosts AI and US equity exposure in $185 billion models

The post BlackRock boosts AI and US equity exposure in $185 billion models appeared on BitcoinEthereumNews.com. BlackRock is steering $185 billion worth of model portfolios deeper into US stocks and artificial intelligence. The decision came this week as the asset manager adjusted its entire model suite, increasing its equity allocation and dumping exposure to international developed markets. The firm now sits 2% overweight on stocks, after money moved between several of its biggest exchange-traded funds. This wasn’t a slow shuffle. Billions flowed across multiple ETFs on Tuesday as BlackRock executed the realignment. The iShares S&P 100 ETF (OEF) alone brought in $3.4 billion, the largest single-day haul in its history. The iShares Core S&P 500 ETF (IVV) collected $2.3 billion, while the iShares US Equity Factor Rotation Active ETF (DYNF) added nearly $2 billion. The rebalancing triggered swift inflows and outflows that realigned investor exposure on the back of performance data and macroeconomic outlooks. BlackRock raises equities on strong US earnings The model updates come as BlackRock backs the rally in American stocks, fueled by strong earnings and optimism around rate cuts. In an investment letter obtained by Bloomberg, the firm said US companies have delivered 11% earnings growth since the third quarter of 2024. Meanwhile, earnings across other developed markets barely touched 2%. That gap helped push the decision to drop international holdings in favor of American ones. Michael Gates, lead portfolio manager for BlackRock’s Target Allocation ETF model portfolio suite, said the US market is the only one showing consistency in sales growth, profit delivery, and revisions in analyst forecasts. “The US equity market continues to stand alone in terms of earnings delivery, sales growth and sustainable trends in analyst estimates and revisions,” Michael wrote. He added that non-US developed markets lagged far behind, especially when it came to sales. This week’s changes reflect that position. The move was made ahead of the Federal…
Share
BitcoinEthereumNews2025/09/18 01:44
Ripple CEO Forecasts Record Performance For Crypto In 2026

Ripple CEO Forecasts Record Performance For Crypto In 2026

The post Ripple CEO Forecasts Record Performance For Crypto In 2026 appeared on BitcoinEthereumNews.com. Ronaldo is an experienced crypto enthusiast dedicated to
Share
BitcoinEthereumNews2026/01/22 13:06